Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancer Chemotherapy and Pharmacology
|
August 14, 2024
Dexamethasone reduces cisplatin-induced hair cell damage by inducing cisplatin resistance through metallothionein-2
Haruki Ujiie, Naoyuki Nishiya, Ami Yamamoto, et al.
Cancer Medicine
|
November 20, 2025
Machine Learning-Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity
Haruki Ujiie, Tomoko Sakyo, Konomi Oya, et al.
In Vivo (Athens, Greece)
|
January 2, 2026
A Prospective Comparison of Azilsartan and Amlodipine for Bevacizumab-induced Hypertension and Proteinuria in Colorectal Cancer
Satoru Nihei, Haruki Ujiie, Kazuki Saito, et al.
Cancer Chemotherapy and Pharmacology
|
November 28, 2023
Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study
Hiroaki Takahashi, Yoko Saito, Kanon Sugawara, et al.
Journal of Pharmaceutical Health Care and Sciences
|
August 31, 2022
Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study
Hiroaki Takahashi, Yukiko Yaegashi, Yoko Saito, et al.
Plos One
|
March 20, 2014
Multimodal effects of small molecule ROCK and LIMK inhibitors on mitosis, and their implication as anti-leukemia agents
Yusuke Oku, Chiaki Tareyanagi, Shinichi Takaya, et al.
Journal of Clinical Pharmacy and Therapeutics
|
June 19, 2021
Analysis of risk factors for skin disorders caused by anti-epidermal growth factor receptor antibody drugs and examination of methods for their avoidance
Hiroaki Takahashi, Junichi Asaka, Tomohiko Tairabune, et al.
Anticancer Research
|
May 6, 2021
Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients
Haruki Ujiie, Satoru Nihei, Naoyuki Nishiya, et al.
Biomedical Reports
|
August 11, 2022
Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab
Takeshi Chiba, Haruki Ujiie, Yukiko Yaegashi, et al.
Iscience
|
May 9, 2022
Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases
Honami Yonezawa, Akari Ikeda, Ryo Takahashi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancer Chemotherapy and Pharmacology
|
August 14, 2024
Dexamethasone reduces cisplatin-induced hair cell damage by inducing cisplatin resistance through metallothionein-2
Haruki Ujiie, Naoyuki Nishiya, Ami Yamamoto, et al.
Cancer Medicine
|
November 20, 2025
Machine Learning-Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity
Haruki Ujiie, Tomoko Sakyo, Konomi Oya, et al.
In Vivo (Athens, Greece)
|
January 2, 2026
A Prospective Comparison of Azilsartan and Amlodipine for Bevacizumab-induced Hypertension and Proteinuria in Colorectal Cancer
Satoru Nihei, Haruki Ujiie, Kazuki Saito, et al.
Cancer Chemotherapy and Pharmacology
|
November 28, 2023
Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study
Hiroaki Takahashi, Yoko Saito, Kanon Sugawara, et al.
Journal of Pharmaceutical Health Care and Sciences
|
August 31, 2022
Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study
Hiroaki Takahashi, Yukiko Yaegashi, Yoko Saito, et al.
Plos One
|
March 20, 2014
Multimodal effects of small molecule ROCK and LIMK inhibitors on mitosis, and their implication as anti-leukemia agents
Yusuke Oku, Chiaki Tareyanagi, Shinichi Takaya, et al.
Journal of Clinical Pharmacy and Therapeutics
|
June 19, 2021
Analysis of risk factors for skin disorders caused by anti-epidermal growth factor receptor antibody drugs and examination of methods for their avoidance
Hiroaki Takahashi, Junichi Asaka, Tomohiko Tairabune, et al.
Anticancer Research
|
May 6, 2021
Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients
Haruki Ujiie, Satoru Nihei, Naoyuki Nishiya, et al.
Biomedical Reports
|
August 11, 2022
Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab
Takeshi Chiba, Haruki Ujiie, Yukiko Yaegashi, et al.
Iscience
|
May 9, 2022
Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases
Honami Yonezawa, Akari Ikeda, Ryo Takahashi, et al.
Page
of 1